worldwide interactive services |
||||
|
worldwide interactive services News for 10-Mar-26 Source: MedicineNet Diabetes General Source: MedicineNet Diabetes General Source: MedicineNet High Blood Pressure General Source: MedicineNet High Blood Pressure General Source: MedicineNet Diabetes General Source: MedicineNet High Blood Pressure General Source: MedicineNet High Blood Pressure General Source: MedicineNet High Blood Pressure General Source: MedicineNet Diabetes General Source: MedicineNet Diabetes General |
The Best worldwide interactive services websiteAll the worldwide interactive services information you need to know about is right
here. Presented and researched by http://www.mdnewscast.net. We've searched
the information super highway far and wide to provide you with the
best worldwide interactive services site on the internet today. The links below will
assist you in your efforts to find the information that you are looking
for about
worldwide interactive services
If you have not already done so, we invite you to click on the link above and take a look at the best worldwide interactive services you will find. We are not trying to sell you but to provide you with the information you need to make a quality decision on your worldwide interactive services purchase. Just in the event you want to research other worldwide interactive services options then click the links on the left side of this page. We are quite sure you will find exactly what you need and your satisfaction is guaranteed. worldwide interactive services
Few sites can survive from advertising revenue alone. The amount of money spent by companies to advertise online palls in comparison to what is spent in media outlets like radio, TV and magazines. With the current economic downtown and the demise of many dotcom companies, online advertising for worldwide interactive services has declined dramatically. Although it is expected to rebound later this year, most of the revenue goes to a handful of large sites. That's where we come in. We have built this worldwide interactive services site to assist you to find the best provider Our website has been logically and simply structured to enable you to navigate the relevant worldwide interactive services links, make direct contact with the relevant worldwide interactive services website, purchase from that website and to return for subsequent trading. Our site map provides you with all the links you will ever need. -Saving Pediatric Drug Becomes Readily Available to Those in Need by: ARA Content
(ARA) - We can all sympathize with the frustration people experience waiting for a new drug that is being tested for a certain disorder. Imagine you have a child with a rare disorder and the only drug effective for treating the disorder is not only extremely hard to obtain, but available only through a nationally-administered random selection process. For many American families, this dilemma is a harsh reality. Patients suffering from a host of difficult to treat orphan disorders have found marked relief from using HP Acthar Gel. Some disorders Acthar helps include seizure complex in babies and young children, referred to as West's syndrome or infantile spasm; Still's disease and ulcerative colitis; Bell's palsy; multiple sclerosis; adrenocortical insufficiency and non-endocrine disorders that are responsive to glucocorticoids. For the past four years, however, the drug has only been available through a limited access program administered by the National Organization for Rare Disorders (NORD), a federation of more that 135 non-profit health organizations serving people with rare disorders. U.S. physicians who were interested in obtaining Acthar Gel for their patients with life-threatening or severely debilitating conditions who did not respond to any other treatment were given first access to the drug. Others with "non-life-threatening" cases had to enroll in a computerized random selection process administered by NORD. An estimated 1,600 patients, primarily suffering from West's syndrome and multiple sclerosis who experience episodes of "flare," have been allowed access to HP Acthar Gel each year for the past four years under the limited access program. More than 5,000 additional patients whose physicians requested the drug were denied. The origins of this drug shortage crisis date back to 1996 when Aventis Pharmaceuticals stopped making Acthar for a few months because of manufacturing difficulties. But now, Questcor Pharmaceuticals, Inc. (AMEX: QSC) has signed an agreement with Aventis to acquire the worldwide rights to HP Acthar Gel. Questcor has also reached a manufacturing agreement with Aventis and will gradually move production to an independent manufacturing facility. As a result, HP Acthar Gel is now back in full production and is returning to normal levels of distribution. Questcor began shipments of HP Acthar Gel to wholesalers the last week of September 2001, giving patients in need access to the product. "We are delighted that Questcor is making this critically important product more widely available after this long period of restricted distribution," said Abbey S. Meyers, president of NORD. "We have been working closely with the company over the last several months to ensure that anyone with a need for Acthar Gel is now able to readily receive the product through more traditional channels. Too many people have suffered as a result of limited access to Acthar Gel." Questcor Pharmaceuticals, Inc. is a fully integrated specialty pharmaceutical company that serves the needs of acute and critical care hospitals with its proprietary products. Visit www.questcor.com for more information on the company and its products. If you are a patient with a disorder that can be treated with Acthar, ask your doctor to contact Questcor Pharmaceuticals at (510) 400-0700. For more information about Acthar, including distribution information, please visit www.Acthar.com.
|
|||
|
http://www.medmeet.com/ |
||||
| Medical Presentations Medical Newscast Go Antiques |